Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06184646 · ClinicalTrials.gov registry record · NA
Elucidating the Minimal Effective Dose of Prunes for Bone Health in Postmenopausal Women
A NA study of Bone Disease, Metabolic, sponsored by San Diego State University.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT06184646: Recruiting NA study of Bone Disease, Metabolic, sponsored by San Diego State University.
NCT06184646 is a NA study of Bone Disease, Metabolic that is actively recruiting participants, run by San Diego State University. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06184646, a NA study of Bone Disease, Metabolic, is actively recruiting participants, sponsored by San Diego State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to examine if calcium and vitamin D supplements and/or prune can prevent bone loss in postmenopausal women.
Primary Outcome
bone mineral density as assessed by dual energy x-ray absorptiometry
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Prune
Study Locations (1)
California
- San Diego State University - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-03-15 |
| Est. Completion | 2028-12 |
| Phase | NA |
What NCT06184646 shows while recruiting
NCT06184646 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Bone Disease, Metabolic appearing as the primary indexed condition, and to 1 intervention - of which Prune is the first listed.
NCT06184646 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06184646 about?
NCT06184646 is a clinical study titled "Elucidating the Minimal Effective Dose of Prunes for Bone Health in Postmenopausal Women". The objective of this study is to examine if calcium and vitamin D supplements and/or prune can prevent bone loss in postmenopausal women.
What is the current status of trial NCT06184646?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-03-15. Estimated completion is 2028-12.
What conditions does trial NCT06184646 study?
This clinical trial studies the following conditions: Bone Disease, Metabolic.
What interventions are being tested in trial NCT06184646?
The interventions under investigation include: Prune (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06184646?
This trial is sponsored by San Diego State University, which has 118 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06184646 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06184646's enrollment target sits among peer trials
200 506th of 2000 higher than 1,435 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI